This comprehensive report provides an in-depth analysis of the global ophthalmic corticosteroid market, projecting significant growth through 2032. It examines key product types, including dexamethasone and loteprednol, and explores diverse application channels ranging from hospital to retail pharmacies. By evaluating regional dynamics across the Americas, APAC, and Europe, the study highlights emerging opportunities and competitive strategies. Furthermore, the report profiles major industry players and assesses market trends, segmentation, and the evolving landscape of anti-inflammatory eye medications.

Market Overview

The global Ophthalmic Corticosteroid market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Product Definition

Ophthalmic corticosteroid is a type of medication specifically formulated for use in the eyes. It belongs to a class of drugs known as corticosteroids, which are synthetic versions of the natural hormones produced by the adrenal glands. These hormones possess powerful anti-inflammatory and immune-suppressing properties.

Regional Market Analysis

United States

The United States market for Ophthalmic Corticosteroid is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.

China

The China market for Ophthalmic Corticosteroid is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.

Europe

The Europe market for Ophthalmic Corticosteroid is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.

Report Scope and Methodology

LPI (LP Information)' newest research report, the “Ophthalmic Corticosteroid Industry Forecast,” examines past sales and reviews total world Ophthalmic Corticosteroid sales in 2025. It provides a comprehensive analysis by region and market sector of projected Ophthalmic Corticosteroid sales for the period of 2026 through 2032. With Ophthalmic Corticosteroid sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Corticosteroid industry.

This Insight Report provides a comprehensive analysis of the global Ophthalmic Corticosteroid landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyses the strategies of leading global companies with a focus on:

• Ophthalmic Corticosteroid portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

This analysis is intended to better understand these firms’ unique position in an accelerating global Ophthalmic Corticosteroid market. The report evaluates key market trends, drivers, and affecting factors shaping the global outlook and breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Corticosteroid market. The report presents a comprehensive overview, market shares, and growth opportunities of the Ophthalmic Corticosteroid market by product type, application, key players, and key regions and countries.

Market Segmentation

By Type

• Difluprednate
• Loteprednol
• Dexamethasone
• Fluorometholone
• Others

By Application

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Research Institute
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Global key Ophthalmic Corticosteroid players include Bausch and Lomb, Alimera Sciences, Allergan, Novartis AG, and GlaxoSmithKline, among others. In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

The following companies have been profiled based on inputs gathered from primary experts and an analysis of the company's coverage, product portfolio, and market penetration:

• Bausch and Lomb
• Alimera Sciences
• Allergan
• Novartis AG
• GlaxoSmithKline
• Genentech
• Pfizer
• Bayer AG
• Regeneron Pharmaceuticals
• Bausch Health
• Ajanta Pharma
• Sun Pharmaceutical
• General Pharmaceuticals
• Orchidia
• Innovative Pharmaceuticals

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Ophthalmic Corticosteroid Market Size (2021-2032)

    • 2.1.2 Ophthalmic Corticosteroid Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Ophthalmic Corticosteroid by Country/Region (2021, 2025 & 2032)

  • 2.2 Ophthalmic Corticosteroid Segment by Type

    • 2.2.1 Difluprednate

    • 2.2.2 Loteprednol

    • 2.2.3 Dexamethasone

    • 2.2.4 Fluorometholone

    • 2.2.5 Others

    • 2.2.6 Ophthalmic Corticosteroid Market Size by Type

      • 2.2.6.1 Ophthalmic Corticosteroid Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.6.2 Global Ophthalmic Corticosteroid Market Size Market Share by Type (2021-2026)

  • 2.3 Ophthalmic Corticosteroid Segment by Application

    • 2.3.1 Hospital Pharmacies

    • 2.3.2 Retail Pharmacies

    • 2.3.3 Online Pharmacies

    • 2.3.4 Research Institute

    • 2.3.5 Others

    • 2.3.6 Ophthalmic Corticosteroid Market Size by Application

      • 2.3.6.1 Ophthalmic Corticosteroid Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.6.2 Global Ophthalmic Corticosteroid Market Size Market Share by Application (2021-2026)

• 3 Ophthalmic Corticosteroid Market Size by Player

  • 3.1 Ophthalmic Corticosteroid Market Size Market Share by Player

    • 3.1.1 Global Ophthalmic Corticosteroid Revenue by Player (2021-2026)

    • 3.1.2 Global Ophthalmic Corticosteroid Revenue Market Share by Player (2021-2026)

  • 3.2 Global Ophthalmic Corticosteroid Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Ophthalmic Corticosteroid by Region

  • 4.1 Ophthalmic Corticosteroid Market Size by Region (2021-2026)

  • 4.2 Global Ophthalmic Corticosteroid Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Ophthalmic Corticosteroid Market Size Growth (2021-2026)

  • 4.4 APAC Ophthalmic Corticosteroid Market Size Growth (2021-2026)

  • 4.5 Europe Ophthalmic Corticosteroid Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Ophthalmic Corticosteroid Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Ophthalmic Corticosteroid Market Size by Country (2021-2026)

  • 5.2 Americas Ophthalmic Corticosteroid Market Size by Type (2021-2026)

  • 5.3 Americas Ophthalmic Corticosteroid Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Ophthalmic Corticosteroid Market Size by Region (2021-2026)

  • 6.2 APAC Ophthalmic Corticosteroid Market Size by Type (2021-2026)

  • 6.3 APAC Ophthalmic Corticosteroid Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Ophthalmic Corticosteroid Market Size by Country (2021-2026)

  • 7.2 Europe Ophthalmic Corticosteroid Market Size by Type (2021-2026)

  • 7.3 Europe Ophthalmic Corticosteroid Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Ophthalmic Corticosteroid by Region (2021-2026)

  • 8.2 Middle East & Africa Ophthalmic Corticosteroid Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Ophthalmic Corticosteroid Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Ophthalmic Corticosteroid Market Forecast

  • 10.1 Global Ophthalmic Corticosteroid Forecast by Region (2027-2032)

    • 10.1.1 Global Ophthalmic Corticosteroid Forecast by Region (2027-2032)

    • 10.1.2 Americas Ophthalmic Corticosteroid Forecast

    • 10.1.3 APAC Ophthalmic Corticosteroid Forecast

    • 10.1.4 Europe Ophthalmic Corticosteroid Forecast

    • 10.1.5 Middle East & Africa Ophthalmic Corticosteroid Forecast

  • 10.2 Americas Ophthalmic Corticosteroid Forecast by Country (2027-2032)

    • 10.2.1 United States Market Ophthalmic Corticosteroid Forecast

    • 10.2.2 Canada Market Ophthalmic Corticosteroid Forecast

    • 10.2.3 Mexico Market Ophthalmic Corticosteroid Forecast

    • 10.2.4 Brazil Market Ophthalmic Corticosteroid Forecast

  • 10.3 APAC Ophthalmic Corticosteroid Forecast by Region (2027-2032)

    • 10.3.1 China Ophthalmic Corticosteroid Market Forecast

    • 10.3.2 Japan Market Ophthalmic Corticosteroid Forecast

    • 10.3.3 Korea Market Ophthalmic Corticosteroid Forecast

    • 10.3.4 Southeast Asia Market Ophthalmic Corticosteroid Forecast

    • 10.3.5 India Market Ophthalmic Corticosteroid Forecast

    • 10.3.6 Australia Market Ophthalmic Corticosteroid Forecast

  • 10.4 Europe Ophthalmic Corticosteroid Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Ophthalmic Corticosteroid Forecast

    • 10.4.2 France Market Ophthalmic Corticosteroid Forecast

    • 10.4.3 UK Market Ophthalmic Corticosteroid Forecast

    • 10.4.4 Italy Market Ophthalmic Corticosteroid Forecast

    • 10.4.5 Russia Market Ophthalmic Corticosteroid Forecast

  • 10.5 Middle East & Africa Ophthalmic Corticosteroid Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Ophthalmic Corticosteroid Forecast

    • 10.5.2 South Africa Market Ophthalmic Corticosteroid Forecast

    • 10.5.3 Israel Market Ophthalmic Corticosteroid Forecast

    • 10.5.4 Turkey Market Ophthalmic Corticosteroid Forecast

  • 10.6 Global Ophthalmic Corticosteroid Forecast by Type (2027-2032)

  • 10.7 Global Ophthalmic Corticosteroid Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Ophthalmic Corticosteroid Forecast

• 11 Key Players Analysis

  • 11.1 Bausch and Lomb

    • 11.1.1 Bausch and Lomb Company Information

    • 11.1.2 Bausch and Lomb Ophthalmic Corticosteroid Product Offered

    • 11.1.3 Bausch and Lomb Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Bausch and Lomb Main Business Overview

    • 11.1.5 Bausch and Lomb Latest Developments

  • 11.2 Alimera Sciences

    • 11.2.1 Alimera Sciences Company Information

    • 11.2.2 Alimera Sciences Ophthalmic Corticosteroid Product Offered

    • 11.2.3 Alimera Sciences Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Alimera Sciences Main Business Overview

    • 11.2.5 Alimera Sciences Latest Developments

  • 11.3 Allergan

    • 11.3.1 Allergan Company Information

    • 11.3.2 Allergan Ophthalmic Corticosteroid Product Offered

    • 11.3.3 Allergan Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Allergan Main Business Overview

    • 11.3.5 Allergan Latest Developments

  • 11.4 Novartis AG

    • 11.4.1 Novartis AG Company Information

    • 11.4.2 Novartis AG Ophthalmic Corticosteroid Product Offered

    • 11.4.3 Novartis AG Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Novartis AG Main Business Overview

    • 11.4.5 Novartis AG Latest Developments

  • 11.5 GlaxoSmithKline

    • 11.5.1 GlaxoSmithKline Company Information

    • 11.5.2 GlaxoSmithKline Ophthalmic Corticosteroid Product Offered

    • 11.5.3 GlaxoSmithKline Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 GlaxoSmithKline Main Business Overview

    • 11.5.5 GlaxoSmithKline Latest Developments

  • 11.6 Genentech

    • 11.6.1 Genentech Company Information

    • 11.6.2 Genentech Ophthalmic Corticosteroid Product Offered

    • 11.6.3 Genentech Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Genentech Main Business Overview

    • 11.6.5 Genentech Latest Developments

  • 11.7 Pfizer

    • 11.7.1 Pfizer Company Information

    • 11.7.2 Pfizer Ophthalmic Corticosteroid Product Offered

    • 11.7.3 Pfizer Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Pfizer Main Business Overview

    • 11.7.5 Pfizer Latest Developments

  • 11.8 Bayer AG

    • 11.8.1 Bayer AG Company Information

    • 11.8.2 Bayer AG Ophthalmic Corticosteroid Product Offered

    • 11.8.3 Bayer AG Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Bayer AG Main Business Overview

    • 11.8.5 Bayer AG Latest Developments

  • 11.9 Regeneron Pharmaceuticals

    • 11.9.1 Regeneron Pharmaceuticals Company Information

    • 11.9.2 Regeneron Pharmaceuticals Ophthalmic Corticosteroid Product Offered

    • 11.9.3 Regeneron Pharmaceuticals Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Regeneron Pharmaceuticals Main Business Overview

    • 11.9.5 Regeneron Pharmaceuticals Latest Developments

  • 11.10 Bausch Health

    • 11.10.1 Bausch Health Company Information

    • 11.10.2 Bausch Health Ophthalmic Corticosteroid Product Offered

    • 11.10.3 Bausch Health Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Bausch Health Main Business Overview

    • 11.10.5 Bausch Health Latest Developments

  • 11.11 Ajanta Pharma

    • 11.11.1 Ajanta Pharma Company Information

    • 11.11.2 Ajanta Pharma Ophthalmic Corticosteroid Product Offered

    • 11.11.3 Ajanta Pharma Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Ajanta Pharma Main Business Overview

    • 11.11.5 Ajanta Pharma Latest Developments

  • 11.12 Sun Pharmaceutical

    • 11.12.1 Sun Pharmaceutical Company Information

    • 11.12.2 Sun Pharmaceutical Ophthalmic Corticosteroid Product Offered

    • 11.12.3 Sun Pharmaceutical Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Sun Pharmaceutical Main Business Overview

    • 11.12.5 Sun Pharmaceutical Latest Developments

  • 11.13 General Pharmaceuticals

    • 11.13.1 General Pharmaceuticals Company Information

    • 11.13.2 General Pharmaceuticals Ophthalmic Corticosteroid Product Offered

    • 11.13.3 General Pharmaceuticals Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 General Pharmaceuticals Main Business Overview

    • 11.13.5 General Pharmaceuticals Latest Developments

  • 11.14 Orchidia

    • 11.14.1 Orchidia Company Information

    • 11.14.2 Orchidia Ophthalmic Corticosteroid Product Offered

    • 11.14.3 Orchidia Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Orchidia Main Business Overview

    • 11.14.5 Orchidia Latest Developments

  • 11.15 Innovative Pharmaceuticals

    • 11.15.1 Innovative Pharmaceuticals Company Information

    • 11.15.2 Innovative Pharmaceuticals Ophthalmic Corticosteroid Product Offered

    • 11.15.3 Innovative Pharmaceuticals Ophthalmic Corticosteroid Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Innovative Pharmaceuticals Main Business Overview

    • 11.15.5 Innovative Pharmaceuticals Latest Developments

• 12 Research Findings and Conclusion